Winslow Evans & Crocker’s QuidelOrtho QDEL Stock Holding History

Winslow Evans & Crocker’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$3K	Hold	15	–	–	﹤0.01%	1193
2020 Q3	$3K	Hold	15	–	–	﹤0.01%	962
2020 Q2	$3K	Sell	15 -1	-6%	-$157	﹤0.01%	988
2020 Q1	$2K	Hold	16	–	–	﹤0.01%	1049
2019 Q4	$2K	Hold	16	–	–	﹤0.01%	1105
2019 Q3	$2K	Hold	16	–	–	﹤0.01%	1096
2019 Q2	$2K	Hold	16	–	–	﹤0.01%	1094
2019 Q1	$2K	Buy	+16	New	+$968	﹤0.01%	1230
2018 Q4	–	Sell	-4,470	Closed	-$292K	–	1126
2018 Q3	$292K	Buy	4,470 +944	+27%	+$66K	0.09%	219
2018 Q2	$236K	Buy	+3,526	New	+$213K	0.07%	231

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winslow Evans & Crocker's QDEL Position: Q4 2020 in Review

Winslow Evans & Crocker held its QuidelOrtho (QDEL) position steady in Q4 2020 at 15 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Winslow Evans & Crocker first reported a position in QDEL in Q2 2018 and has held it in 10 quarters since. The position peaked at $292K in Q3 2018. 386 funds tracked by Wall St. Rank hold QDEL as of Q4 2020.

Winslow Evans & Crocker held 15 shares of QuidelOrtho worth $3K as of Q4 2020.
Winslow Evans & Crocker left its QuidelOrtho share count unchanged in Q4 2020.
QuidelOrtho made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1193 holding.
Winslow Evans & Crocker first reported a position in QuidelOrtho in Q2 2018 and has held it in 10 quarters since.
Winslow Evans & Crocker's QuidelOrtho position peaked at $292K in Q3 2018.
386 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.